- Originally created to reduce nausea and vomiting in patients after chemotherapy, radiation or other serious surgeries
- Prescribed to pregnant women to reduce nausea, though it has not been approved to treat morning sickness
- Generic name is Ondansetron, first approved by the Food and Drug Administration in 1991
- 30 percent increased risk of birth defects and a doubled risk of heart defects in infants
- In September 2011, the FDA announced that a 32 mg dose of Zofran can change the electrical chemistry of the heart and cause fatal heart rhythms.
- The drug was recalled and the FDA stated the drug should not be prescribed in an amount over 16 mg.
Friedman Law Offices is here to help. To schedule a free consultation with our attorneys about a dangerous drug, contact us online in Lincoln, Nebraska, or by calling 866-458-5468 or toll free 888-419-6876.